NASDAQ
CDNA
Last Price
US $28.93
KEY FIGURES
MKT CAP
$1.5B
EPS
TTM
$-0.16
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
3.58x
YIELD
0.00%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
-2.61%
Return on equity
ROIC: -3.90%
Valuation History
-180.3X
Price to Earnings
EV/EBITDA: 132.7X
Cash flow
Profit margin
14.59%
(FY vs FY)
EBITDA Y/Y
65.06%
(FY vs FY)
Cash flow Y/Y
9.38%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $28.93
-54.89%
Default assumptions
EBITDA Multiple
Fair Value
Market $28.93
-97.23%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
CareDx, Inc cash flow to debt ratio of 160.46% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial stability - Healthy cash flow growth.
CareDx, Inc's free cash flow has increased 14.43% from $31.56M last year to $36.12M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
CareDx, Inc's debt to equity ratio is 0.08, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
CareDx, Inc's debt has increased relative to shareholder equity from 0.07 last year to 0.08 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
CareDx, Inc has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
CareDx, Inc earns at least as much interest as it pays. Interest obligations are fully covered.
Financial risk - Profit margin growth.
CareDx, Inc's profit margin has decreased (-112.61%) in the last year from 15.74% to -1.98%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
CareDx, Inc's short-term assets of $257.13M exceed its short-term liabilities of $89.85M
Decreasing performance - ROA.
CareDx, Inc's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
CareDx, Inc's return on equity of -2.61%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
CareDx, Inc's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
CareDx, Inc had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Increasing performance - Free cash flow.
CareDx, Inc has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
CareDx, Inc has a free cash flow yield of 2.42%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
CareDx, Inc's yearly earnings has decreased -140.64% since last year from $52.55M to $-21.35M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
CareDx, Inc's yearly revenue has increased 13.79% since last year from $333.79M to $379.81M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -3.90% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
CareDx, Inc's 3-year revenue CAGR of 5.68% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
CareDx, Inc had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
CareDx, Inc had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
CareDx, Inc is overvalued relative to its fair value price of 13.05 based on Discounted Cash Flow model
Overvalued - Earnings yield.
CareDx, Inc has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
CareDx, Inc is overvalued relative to its fair value price of 0.80 based on EBITDA multiple model
Overvalued - EV/EBITDA.
CareDx, Inc has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
CareDx, Inc has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
CareDx, Inc has a price-to-book ratio of 4.72x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
CareDx, Inc has a price-to-sales ratio of 3.58x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue